{"organizations": [], "uuid": "155bf7c6b217322c1d8a227e8ffaf76f66e7d586", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-fortress-global-enterprises-to-acq/brief-fortress-global-enterprises-to-acquire-s2g-biochemicals-for-2-5-mln-idUSASC09SLS", "country": "US", "domain_rank": 408, "title": "BRIEF-Fortress Global Enterprises to acquire S2G Biochemicals for $2.5 mln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-16T04:05:00.000+02:00", "replies_count": 0, "uuid": "155bf7c6b217322c1d8a227e8ffaf76f66e7d586"}, "author": "", "url": "https://www.reuters.com/article/brief-fortress-global-enterprises-to-acq/brief-fortress-global-enterprises-to-acquire-s2g-biochemicals-for-2-5-mln-idUSASC09SLS", "ord_in_thread": 0, "title": "BRIEF-Fortress Global Enterprises to acquire S2G Biochemicals for $2.5 mln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-fortress global enterprises", "sentiment": "negative"}, {"name": "reuters) - fortress global enterprises inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 16, 2018 / 2:08 AM / Updated 11 minutes ago BRIEF-Fortress Global Enterprises to acquire S2G Biochemicals for $2.5 mln Reuters Staff March 15 (Reuters) - Fortress Global Enterprises Inc : * FORTRESS GLOBAL ENTERPRISES ANNOUNCES ACQUISITION OF S2G BIOCHEMICALS INC. AND NEW XYLITOL PROJECT * ‍WILL ACQUIRE ALL OF ISSUED AND OUTSTANDING COMMON SHARES OF S2G FOR A PURCHASE PRICE OF $2.5 MILLION * ‍IT HAS SIGNED A SHARE PURCHASE AGREEMENT WITH S2G BIOCHEMICALS INC AND ITS SHAREHOLDERS​ * FORTRESS GLOBAL ENTERPRISES-‍PURCHASE PRICE PAYABLE BY ISSUANCE OF 666,652 COMMON SHARES OF COMPANY AT A DEEMED PRICE OF $3.75 PER FORTRESS GLOBAL SHARE​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-16T04:05:00.000+02:00", "crawled": "2018-03-16T04:28:47.035+02:00", "highlightTitle": ""}